Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes
This case-control study examines the use of glucagon-like peptide-1 receptor agonist before metabolic and bariatric surgery and its postoperative outcome.
Authors
- Vasundhara Mathur (ORCID: https://orcid.org/0000-0002-6395-750X)
- Abdelrahman Ali Nimeri (ORCID: https://orcid.org/0000-0001-7844-163X)
- Pourya Medhati (ORCID: https://orcid.org/0000-0001-6684-3439)
- Ali Tavakkoli (ORCID: https://orcid.org/0000-0002-7430-1848)
- Eric G. Sheu (ORCID: https://orcid.org/0000-0003-2707-1768)
- Katherine Wasden
- Thomas Shin (ORCID: https://orcid.org/0000-0002-6845-2463)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Surgery
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1001/jamasurg.2025.0001
- Citations
- 19
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 38.12